AI-empowered Real-time COVID-19 Symptom Monitoring and Prediction among Senior Residents
- Funded by Roche Holding AG (Roche)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Funder
Roche Holding AG (Roche)Principal Investigator
Samira RahimiResearch Location
CanadaLead Research Institution
McGill UniversityResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Diagnostics
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Not applicable
Broad Policy Alignment
Pending
Age Group
Adults (18 and older)Older adults (65 and older)
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
Long-term care (LTC) homes are being disproportionately affected by COVID-19. This project will implement proven remote monitoring technology empowered with Artificial Intelligence to track, monitor and predict senior residents' symptoms. The detection and prediction of asymptomatic changes will facilitate rapid isolation and can save thousands of lives. The technology will alert the providers when COVID-19 symptoms are identified/predicted and monitor any decompensation. This project will monitor 60 senior residents in two LTC homes (Toronto and Montreal) and then scale up for the entire LTC homes, and intends to protect LTC home staff and frail residents from exposure to COVID-19 by enabling remote monitoring.